Kura Oncology launches Caspian Therapeutics with $50 million financing
Kura Oncology launched Caspian Therapeutics with $50 million financing to advance menin inhibition for diabetes.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.